Products - Out-licensing

Disclaimer: Availability of products is subject to patent restrictions in countries where applicable patents are in effect.

Download PDF
Product Name Strength and Dosage form Brand/Innovator Indication Dossier Availability
LAPATINIB 250mg Film-coated tablets Tyverb® (Novartis) Breast cancer Available
LETROZOLE 2.5mg Film-coated tablets Femara® (Novartis) Breast cancer Available
VENETOCLAX 10mg, 50mg & 100mg Film-coated tablets Venclyxto® (Abbvie) Leukemia Under Development
METHOTREXATE 2.5mg Film-coated tablets Novatrex® (Pfizer) Leukemia, non-Hodgkin's lymphoma Available
ABIRATERONE ACETATE 250mg, 500mg & 1000mg Film-coated tablets Zytiga® (Janssen) Prostate cancer Available
ENZALUTAMIDE 40mg & 80mg Film-coated tablets Xtandi® (Astellas) Prostate cancer Under Development
PAZOPANIB (as hydrochloride) 200mg & 400mg Film-coated tablets Votrient® (Novartis) Renal cell cancer Available
LINAGLIPTIN 5mg Film-Coated Tablets Tradjenta® (Boehringer) Type 2 - Diabetes Mellitus Available
ENALAPRIL MALEATE 5mg, 10mg & 20mg Tablets Xanef® (MSD Sharp & Dohme GMBH) Heart failure, Hypertension Available
METHYLDOPA 250mg Film-coated tablets Aldomet® (H.A.C PHARMA) Hypertension Available

* Available for distribution only.